- Companies
- Krebs Biochemicals
Krebs Biochemicals Valuation Multiples
Krebs Biochemicals is valued at $13M as of November 2026, a 14.7x revenue multiple. In the last fiscal year, Krebs Biochemicals revenue was $3M and Krebs Biochemicals EBITDA was ($383K).
Krebs Biochemicals Overview
About Krebs Biochemicals
Krebs Biochemicals & Industries Ltd is a biochemical company in India. It is engaged in the business of manufacture of active pharmaceutical ingredients. It has two manufacturing plants in Andhra Pradesh, India - one in Nellore and one in Vizag both Units are equipped for chemical synthesis, fermentation, and enzymatic technologies providing Krebs with production capacity.
Founded
1991
HQ
Employees
202
Website
Financials (Last FY)
EV
$37M
Valuation Multiples
Start free trialKrebs Biochemicals Financials
Krebs Biochemicals reported last fiscal year revenue of $3M and negative EBITDA of ($383K).
In the same fiscal year, Krebs Biochemicals generated $1M in gross profit, ($383K) in EBITDA losses, and had net loss of ($2M).
Krebs Biochemicals P&L
In the most recent fiscal year, Krebs Biochemicals reported revenue of $3M and EBITDA of ($383K).
Krebs Biochemicals is unprofitable as of last fiscal year, with gross margin of 56%, EBITDA margin of (15%), and net margin of (71%).
Financial data powered by Morningstar, Inc.
Krebs Biochemicals Stock Performance
Krebs Biochemicals has current market cap of $13M, and enterprise value of $37M.
Market Cap Evolution
Krebs Biochemicals' stock price is $0.61.
Krebs Biochemicals has an EPS (earnings per share) of $-0.08.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $37M | $13M | -2.1% | - | - | - | $-0.08 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialKrebs Biochemicals Valuation Multiples
Krebs Biochemicals trades at 14.7x EV/Revenue multiple, and (97.8x) EV/EBITDA.
Krebs Biochemicals Financial Valuation Multiples
As of November 20, 2026, Krebs Biochemicals has market cap of $13M and EV of $37M.
Krebs Biochemicals has a P/E ratio of (7.2x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Krebs Biochemicals Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Krebs Biochemicals Margins & Growth Rates
In the most recent fiscal year, Krebs Biochemicals reported gross margin of 56%, EBITDA margin of (15%), and net margin of (71%).
Krebs Biochemicals Margins
Data powered by FactSet, Inc. and Morningstar, Inc.
Krebs Biochemicals Operational KPIs
Krebs Biochemicals' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Krebs Biochemicals Competitors
Krebs Biochemicals competitors include Bolt Biotherapeutics, Pharma Equity Group, Celyad Oncology, Biophytis, Fractyl Health, Citius Pharmaceuticals, Actuate Therapeutics, Seres Therapeutics, BioStem Technologies and Pluri.
Most Krebs Biochemicals public comparables operate across Chemicals, Biopharmaceuticals and BioTech.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $8M | ($35M) | 2.5x | 11.3x | (0.6x) | - | |||
| - | ($3M) | - | - | (4.2x) | - | |||
| $23K | ($1M) | 568.3x | - | (9.7x) | - | |||
| - | ($10M) | - | 99.4x | (1.9x) | (0.8x) | |||
| - | ($141M) | - | - | (0.3x) | (0.6x) | |||
| - | ($38M) | - | 1.1x | (0.3x) | - | |||
| - | ($22M) | - | - | (0.5x) | - | |||
| $789K | ($62M) | 40.3x | 4.4x | (0.5x) | - | |||
This data is available for Pro users. Sign up to see all Krebs Biochemicals competitors and their valuation data. Start Free Trial | ||||||||
Krebs Biochemicals VC Funding History
Before going public, Krebs Biochemicals raised funding across 1 round.
Last private valuation of Krebs Biochemicals was $8M, after raising a round in February 2015 from Ipca Laboratories.
Krebs Biochemicals Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Krebs Biochemicals
| When was Krebs Biochemicals founded? | Krebs Biochemicals was founded in 1991. |
| Where is Krebs Biochemicals headquartered? | Krebs Biochemicals is headquartered in India. |
| How many employees does Krebs Biochemicals have? | As of today, Krebs Biochemicals has over 202 employees. |
| Is Krebs Biochemicals publicly listed? | Yes, Krebs Biochemicals is a public company listed on Bombay Stock Exchange. |
| What is the stock symbol of Krebs Biochemicals? | Krebs Biochemicals trades under 524518 ticker. |
| When did Krebs Biochemicals go public? | Krebs Biochemicals went public in 1996. |
| Who are competitors of Krebs Biochemicals? | Krebs Biochemicals main competitors include Bolt Biotherapeutics, Pharma Equity Group, Celyad Oncology, Biophytis, Fractyl Health, Citius Pharmaceuticals, Actuate Therapeutics, Seres Therapeutics, BioStem Technologies, Pluri. |
| What is the current market cap of Krebs Biochemicals? | Krebs Biochemicals' current market cap is $13M. |
| What is the current revenue of Krebs Biochemicals? | Krebs Biochemicals' last fiscal year revenue is $3M. |
| What is the current EV/Revenue multiple of Krebs Biochemicals? | Current revenue multiple of Krebs Biochemicals is 14.7x. |
| Is Krebs Biochemicals profitable? | No, Krebs Biochemicals is not profitable. |
| How many companies Krebs Biochemicals has acquired to date? | Krebs Biochemicals hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Krebs Biochemicals has invested to date? | Krebs Biochemicals hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Krebs Biochemicals
Lists including Krebs Biochemicals
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




